We’re Stronger Together
With your help, we can advance education and improve student success in our community.
Research Projects & Grants
For Profit Organization
- P-CDI9CD20-ALLOI-001: Open-Label, Muticenter, Phase 1 Study to Assess the Safety of P-CDl9CD20-ALLO1 in Subjects with Selected Relapsed/Refractory B cell Malignancies, Role: Investigator, Poseida Therapeutics Inc., (12/2025 - 12/2026) Status: Approved
- CYTB323J12201: A Phase 2, Open-label, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel in Patients Suffering with active, refractory Systemic Lupus Erythematosus (SLE) or Active, Refractory Lupus Nephritis (LN), Role: Investigator, Novartis Pharmaceuticals Corporation, (07/2026 - 07/2027) Status: Approved